CVS Health Co. (NYSE:CVS) Shares Bought by Empirical Finance LLC

Empirical Finance LLC lifted its position in shares of CVS Health Co. (NYSE:CVS) by 17.8% in the fourth quarter, Holdings Channel reports. The firm owned 52,588 shares of the pharmacy operator’s stock after purchasing an additional 7,959 shares during the period. Empirical Finance LLC’s holdings in CVS Health were worth $2,361,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CVS. Moloney Securities Asset Management LLC increased its position in shares of CVS Health by 2.7% in the fourth quarter. Moloney Securities Asset Management LLC now owns 27,305 shares of the pharmacy operator’s stock worth $1,226,000 after acquiring an additional 708 shares in the last quarter. Kingsview Wealth Management LLC boosted its position in CVS Health by 9.1% during the 4th quarter. Kingsview Wealth Management LLC now owns 184,634 shares of the pharmacy operator’s stock worth $8,288,000 after purchasing an additional 15,400 shares during the period. Cantor Fitzgerald Investment Advisors L.P. increased its holdings in CVS Health by 6.0% in the 4th quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 404,443 shares of the pharmacy operator’s stock valued at $18,155,000 after purchasing an additional 22,926 shares in the last quarter. Vest Financial LLC lifted its stake in shares of CVS Health by 18.3% during the fourth quarter. Vest Financial LLC now owns 9,630 shares of the pharmacy operator’s stock worth $432,000 after purchasing an additional 1,492 shares in the last quarter. Finally, Cidel Asset Management Inc. boosted its position in shares of CVS Health by 7.9% in the fourth quarter. Cidel Asset Management Inc. now owns 31,943 shares of the pharmacy operator’s stock worth $1,434,000 after buying an additional 2,341 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CVS. Evercore ISI upped their price target on CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a report on Monday, January 27th. Piper Sandler decreased their target price on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Royal Bank of Canada dropped their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. Finally, Barclays cut their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Price Performance

Shares of NYSE CVS opened at $53.95 on Monday. The firm has a 50-day moving average of $50.79 and a two-hundred day moving average of $55.99. The company has a market capitalization of $67.90 billion, a price-to-earnings ratio of 13.69, a PEG ratio of 0.60 and a beta of 0.61. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.93%. The ex-dividend date was Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.